Clinical Trials Directory

Trials / Completed

CompletedNCT03978962

Performance and Safety of the Resorbable Collagen Membrane "Ez Cure"

Performance and Safety of the Resorbable Collagen Membrane "Ez Cure" in Guided Tissue Regeneration and Guided Bone Regeneration Procedures

Status
Completed
Phase
Study type
Observational
Enrollment
56 (actual)
Sponsor
Biomatlante · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The evaluation of the clinical data has demonstrated the conformity of the Resorbable Collagen Membrane (RCM), EZ CureTM, with the relevant essential requirements for its use in periodontal applications. The RCM is intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR) procedures. It acts as a barrier against the migration of epithelial cells within the bone defect (performance) and thus complies with several surgical indications in the treatment of maxillofacial bone defects. It has been concluded that the risks associated with the use of this device are acceptable when weighted against the benefits to the patients. In order to improve the clinical data on the RCM, the manufacturer, Biomatlante, decided to assess that the performance and safety of the device are maintained until the reaching of its intended use. In this objective, the goal of this study will be to observe the following parameters: 1. Tissue regeneration (mucosa health on the site of implantation) 2. Safety (report of any adverse event) 3. Radiographic analysis of periodontal tissues

Conditions

Interventions

TypeNameDescription
DEVICEGuided Tissue RegenerationCovering oral-maxillofacial or a periodontal defects with the Resorbable Collagen Membrane in order to avoid epithelial cell infiltration and to promote periodontal tissues healing. Covering alveolar bone defects after tooth-teeth extraction.

Timeline

Start date
2019-05-28
Primary completion
2020-08-26
Completion
2020-08-26
First posted
2019-06-07
Last updated
2025-02-04

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03978962. Inclusion in this directory is not an endorsement.